Stan Sujka
Urology · Orlando, FLNPI 1407844681
Payments from drug & device makers
Across 341 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$2K
- Johnson & Johnson$909
- Myriad Genetic Laboratories, Inc.$586
- Bayer$512
- Coloplast$422
- AbbVie$366
- plus $3K from 34 others
What the payments were for
- Consulting fees$1,14015%
- Food & beverage$6,24981%
- Education$3194%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 61 | $2,108 |
| Johnson & Johnson(2 entities) | 45 | $909 |
| Myriad Genetic Laboratories, Inc. | 28 | $586 |
| Bayer | 29 | $512 |
| Coloplast | 15 | $422 |
| AbbVie(2 entities) | 18 | $366 |
| Endo Pharmaceuticals Inc. | 15 | $301 |
| Dendreon Pharmaceuticals LLC | 12 | $255 |
| Pfizer | 15 | $245 |
| Boston Scientific | 8 | $185 |
| Neotract Inc. | 4 | $169 |
| Myovant Sciences Inc. | 9 | $162 |
| Sumitomo Pharma America, Inc. | 8 | $137 |
| Alnylam Pharmaceuticals Inc. | 6 | $129 |
| Olympus America Inc. | 5 | $101 |
| Blue Earth Diagnostics | 5 | $98 |
| Merck | 4 | $96 |
| Teleflex LLC | 5 | $95 |
| Acerus Pharmaceuticals Corporation | 6 | $92 |
| Axonics, Inc. | 4 | $81 |
| Novartis | 4 | $66 |
| Verity Pharmaceuticals Inc. | 4 | $63 |
| KARL Storz Endoscopy-america | 3 | $61 |
| Tolmar Pharmaceuticals, Inc. | 3 | $57 |
| Antares Pharma, Inc. | 3 | $45 |
| Urovant Sciences Inc | 3 | $44 |
| Tolmar, Inc. | 2 | $43 |
| Urogen Pharma, Inc. | 3 | $40 |
| AstraZeneca | 2 | $37 |
| Metuchen Pharmaceuticals | 2 | $35 |
| 180 Medical, Inc. | 1 | $30 |
| Sagent Pharmaceuticals | 1 | $23 |
| BD | 1 | $23 |
| EDAP Technomed Inc | 1 | $18 |
| Medtronic | 1 | $18 |
| Travere Therapeutics, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Dornier Medtech America, Inc | 1 | $13 |
| Rigicon,inc. | 1 | $9 |
| Clarus Therapeutics Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,708 in reported general payments places this provider in the 65th percentile of 935 urology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 31 | $15,884 |
| Tamsulosin Hcl | 81 | $1,368 |
| Finasteride | 86 | $1,056 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 28 | $639 |
| Dutasteride | 16 | $619 |
| Bicalutamide | 12 | $318 |
| Ciprofloxacin Hcl | 15 | $119 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $2,108 | $15,88431 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 935 urology providers in Florida.
Other urology in Orlando
- Lucas WiegandOrlando$587K
- Olubayo TojuolaOrlando$283K
- Inoel Rivera-RamirezOrlando$277K
- Jeffrey BradyOrlando$164K
- Steven KesterPompano Beach$5.7M
- Harvey SamowitzHallandale Beach$3.6M
- Paul PeritoCoral Gables$3.6M
- Graham GreeneLakeland$2.5M
- Scott SellingerTallahassee$2.3M
- Fernando BiancoHialeah$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.